EyePoint

EyePoint announces the first patients dosed in both of our global Phase 3 clinical trials for the treatment of diabetic macular edema (DME).

🔎The only sustained release TKI in Phase 3 clinical trials for DME
2️⃣ Global, non-inferiority clinical trials: COMO & CAPRI
📈 Topline data expected 2H 2027

👉 Read more here: https://investors.eyepoint.bio/news-releases/news-release-details/eyepoint-announces-first-patients-dosed-both-global-phase-3?utm_source=fb&utm_medium=organic_mar26&utm_campaign=dmefpd

Wet AMD is the leading cause of vision loss and irreversible blindness in people over 50. The high treatment burden often leads to missed appointments and possible irreversible vision loss.

This AMD and Low Vision Awareness Month, reinforces our commitment to developing longer-acting therapies to improve vision and reduce the treatment burden for patients and caregivers.

We are a proud partner of Prevent Blindness, whose advocacy plays a vital role in the fight against .

Join us in recognizing :

https://preventblindness.org/2026-amd-low-vision-month/

When it comes to matters of sight, innovation is our vision.

We’re advancing a potential novel multi-mechanism of action for wet AMD and DME - the largest retinal disease markets where there is a significant need for new therapeutic options.

See more on our programs: https://eyepoint.bio/our-programs/?utm_source=fb&utm_medium=organic_feb26&utm_campaign=multimoatki

This and Low Vision Month, we’re proud to support Prevent Blindness in our shared commitment to improving the lives of patients with serious retinal diseases.

Find resources for patients and professionals on living with low vision, facts and stats on eyes, and explore advocacy initiatives at https://preventblindness.org/

As we close out the year, we were grateful to celebrate the incredible EyePoint team at our annual holiday party.

Every day, their dedication, teamwork, and creativity drive our mission to develop innovative therapeutics to improve the lives of patients with serious retinal diseases.

Together, we’ve reached major milestones and progressed forward – setting the stage for even greater achievements in the year ahead.

Wishing everyone a joyful holiday season!